BioPharma Credit (LON:BPCR) Stock Price Up 0.3% – Should You Buy?

Shares of BioPharma Credit (LON:BPCRGet Free Report) traded up 0.3% on Tuesday . The company traded as high as GBX 0.90 and last traded at GBX 0.89. 1,229,705 shares changed hands during trading, an increase of 5% from the average session volume of 1,168,145 shares. The stock had previously closed at GBX 0.89.

BioPharma Credit Stock Up 0.3%

The company has a market cap of £10.04 million, a PE ratio of 0.08 and a beta of 0.22. The firm has a 50 day simple moving average of GBX 0.91 and a 200-day simple moving average of GBX 0.89.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

Further Reading

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.